课题基金 / 基金详情

项目摘要

项目成果

William P Fay的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的目标是为创新的电子鼻系统建立健壮的、概念验证的可行性, 名为MOF-SCHINT系统,用于无症状和有症状的实时和非侵入性筛查 新冠肺炎患者,基于呼气中VOCs的检测具有较高的准确性。这个 提出的基于OE-HCCR-MOF的电子鼻传感器是一种新型的生物传感和化学传感技术, 由于提高了灵敏度和选择性,将从根本上推动电子鼻传感技术的发展。
英文摘要
The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system, termed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic COVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The proposed OE-HCCR-MOF based E-nose sensor is a novel biosensing and chemical sensing technology that will fundamentally advance E-nose sensing technologies due to the improved sensitivity and selectivity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence
Midwest Biomedical Accelerator Consortium: MBArC
  • 批准号:
    10230468
  • 项目类别:
  • 资助金额:
    $117.16万
  • 财政年份:
    2020
  • 负责人:
    William P Fay
  • 依托单位:
Midwest Biomedical Accelerator Consortium: MBArC
  • 批准号:
    10475264
  • 项目类别:
  • 资助金额:
    $98.1万
  • 财政年份:
    2019
  • 负责人:
    William P Fay
  • 依托单位:
海外基金